[FURL=https://www.industryarc.com/Report/16867/reperfusion-injury-market.html]Reperfusion Injury Market[/FURL] size is forecast to reach $2.14 billion by 2025, growing at a CAGR of 6.09% during the forecast period 2020-2025.Reperfusion injury is the tissue damage caused when blood supply returns to tissue ischemia and it is also known as Ischemia Reperfusion Injury. Increase in the tissue damage and increase of fluid filtration across the tissue are the major factors driving the growth of the market. Rise in awareness of reperfusion injury and increasing R&D development is set to further enhance the overall market demand of reperfusion injury during the forecast period 2020-2025. Key Takeaways
North America dominated the Reperfusion Injury Market in 2019 owing to increase in the tissue damage and presence of better healthcare infrastructure. The Reperfusion Injury Market scope for different regions will be provided in the final report.
Increase in the use of Allopurinol and an enzyme recombinant superoxide against the reperfusion injury is likely to aid in the market growth of reperfusion market.
Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Reperfusion Injury Market report.
High cost of the reperfusion injury treatment and the risk factors like hypertension
is set to create hurdles for the Reperfusion Injury Market.
Request for Sample of the Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=16867[/FURL]
Geography - Segment Analysis
North America dominated the reperfusion injury market in 2019 with a share of more than 41.2%, followed by Europe owing to the better technique for rapid reperfusion and use of neutrophil inhibitors and anti-oxidants that helps in reduction of enormous cost associated with the clinical traits of the reperfusion injury.
However, Europe is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the pathophysiological mechanisms and pharmacological therapeutic strategies, for preventing myocardial reperfusion injury.
Drivers – Reperfusion Injury Market
Increase in the use of Allopurinol
Increase in the tissue damage and increase of fluid filtration across the tissue
Reperfusion Injury Industry Outlook: Reperfusion Injury, top 10 companies are Omeros Corporation, Erimos Pharmaceuticals, Prolong Pharmaceuticals,Orexo AB , Eustralis Pharmaceuticals Ltd. , Stealth Peptides , Vasade Biosciences , Opsona Therapeutics Limited and Pharming Group N.V. among others.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.